Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddys's Laboratories Limited Under Non-Fasting Conditions

NCT01132027 ↗

Phase 1 Completed 40 enrolled Dr. Reddy's Laboratories Limited

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the relative bioavailability study of tacrolimus capsules 5 mg with prograf capsules 5 mg in healthy, adult, human subjects under non-fasting conditions and to monitor safety of subjects.

Timeline

Start: 2008-01
Primary completion: 2008-02
Completion: 2008-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tacrolimus	Small molecule	5 mg	—

Indications

No indication recorded.